IL6 and graft versus host disease: Additionally, Ono [9] reported that in humanized mice, produced via the transplantation of hu-HSCs into human IL-6 transgenic NSG mice, the subsequent overproduction of IL-6 activated T-cells and macrophages, resulting in late-onset lethal GVHD.